Cargando…
The FDA-Approved Essure Device Counseling Order Fails to Promote Patient Empowerment
Autores principales: | Gunn, Christine M., Paasche-Orlow, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SLACK Incorporated
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607766/ https://www.ncbi.nlm.nih.gov/pubmed/31289791 http://dx.doi.org/10.3928/24748307-20190306-01 |
Ejemplares similares
-
Challenges in Removing the Essure(®) Device
por: van Gastel, Daniëlle M., et al.
Publicado: (2020) -
The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021) -
First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016) -
An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023) -
The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.
por: Olivier, Timothée, et al.
Publicado: (2022)